BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26666150)

  • 21. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
    McCullough PA; Bakris GL; Owen WF; Klassen PS; Califf RM
    Am Heart J; 2004 Aug; 148(2):243-51. PubMed ID: 15308993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H; Sone H; Oishi M; Kawai K; Fukumoto Y; Kobayashi M;
    Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical therapeutic strategies for early stage of diabetic kidney disease.
    Kitada M; Kanasaki K; Koya D
    World J Diabetes; 2014 Jun; 5(3):342-56. PubMed ID: 24936255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of nephropathy in patients with type 2 diabetes.
    Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
    Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetes and the kidneys].
    Stein G; Schmechel H
    Z Arztl Fortbild Qualitatssich; 2002 Mar; 96(3):175-82. PubMed ID: 12017761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic nephropathy; clinical stage and prediction].
    Kaizu K; Komine N
    Rinsho Byori; 2001 Dec; 49(12):1205-11. PubMed ID: 11797389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.
    Halimi JM
    Diabetes Metab; 2012 Oct; 38(4):291-7. PubMed ID: 22622176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetic nephropathy].
    Haneda M
    Nihon Rinsho; 2015 Mar; 73(3):489-94. PubMed ID: 25812379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic nephropathy -- a multifaceted target of new therapies.
    Choudhury D; Tuncel M; Levi M
    Discov Med; 2010 Nov; 10(54):406-15. PubMed ID: 21122472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetes mellitus and chronic kideny disease: modern diagnostics and treatment].
    Shestakova MV
    Vestn Ross Akad Med Nauk; 2012; (1):45-9. PubMed ID: 22550710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney disease as CVD risk factor: implications for therapy.
    Cardiovasc J S Afr; 2005; 16(2):128-9. PubMed ID: 15915283
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
    Ayodele OE; Alebiosu CO; Salako BL
    J Natl Med Assoc; 2004 Nov; 96(11):1445-54. PubMed ID: 15586648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Klin Med (Mosk); 2010; 88(1):32-7. PubMed ID: 20369609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country.
    Bentata Y; Chemlal A; Karimi I; El Alaoui F; Haddiya I; Abouqal R
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):1035-43. PubMed ID: 26354588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR.
    Gambaro G; Bonfante L; Abaterusso C; Gemelli A; Ferraro PM; Marchesini S; De Conti G; D'Angelo A; Lupo A
    Nephrol Dial Transplant; 2012 Feb; 27(2):746-51. PubMed ID: 21737518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance in diabetic nephropathy--cause or consequence?
    Svensson M; Eriksson JW
    Diabetes Metab Res Rev; 2006; 22(5):401-10. PubMed ID: 16703644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.